142 related articles for article (PubMed ID: 15211188)
1. Preface.
Vavvas D; Gragoudas ES; Hatton MP
Int Ophthalmol Clin; 2004; 44(3):xiii. PubMed ID: 15211188
[No Abstract] [Full Text] [Related]
2. [Collyrex collyrium in patients wearing soft lenses].
Caissial C; Chanteclair G; Reny A
Bull Soc Ophtalmol Fr; 1983 Feb; 83(2):213-6. PubMed ID: 6193899
[No Abstract] [Full Text] [Related]
3. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
4. Considerations for randomizing 1 eye or 2 eyes.
Bunce C; Wormald R
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291489
[No Abstract] [Full Text] [Related]
5. Considerations for randomizing 1 eye or 2 eyes--reply.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291566
[No Abstract] [Full Text] [Related]
6. Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Jan; 133(1):9-10. PubMed ID: 25256889
[No Abstract] [Full Text] [Related]
7. Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
Bisen AC; Srivastava S; Mishra A; Sanap SN; Biswas A; Choudhury AD; Dubey A; Gupta NM; Yadav KS; Mugale MN; Bhatta RS
J Ocul Pharmacol Ther; 2024 Jun; 40(5):261-280. PubMed ID: 38654153
[No Abstract] [Full Text] [Related]
8. [Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
Filho PA; Maia M; Rodrigues EB; Farah ME
Arq Bras Oftalmol; 2010; 73(3):294-9. PubMed ID: 20730292
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
10. Use of drugs in the eye.
Ellis PP
GP; 1968 Oct; 38(4):99-108. PubMed ID: 5679524
[No Abstract] [Full Text] [Related]
11. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
12. Ocular application of chitosan.
Başaran E; Yazan Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
[TBL] [Abstract][Full Text] [Related]
13. Potential use of ocular-insert therapy in dry eyes.
Pavan-Langston D
Int Ophthalmol Clin; 1973; 13(1):231-8. PubMed ID: 4724259
[No Abstract] [Full Text] [Related]
14. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine.
Fraunfelder FT; Meyer SM
Am J Ophthalmol; 1985 Mar; 99(3):362-3. PubMed ID: 3976814
[No Abstract] [Full Text] [Related]
15. [Ophthalmologic examination on tolerance and therapeutic effect of Visuphrine].
Rathke W
Med Monatsschr; 1970 Mar; 24(3):125-6. PubMed ID: 5461772
[No Abstract] [Full Text] [Related]
16. [The use of magnetic fields in ophthalmology].
Skrinnik AV; Moiseeva NN
Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478
[No Abstract] [Full Text] [Related]
17. Topical ophthalmic drugs and the pediatric patient.
Chung I; Buhr V
Optometry; 2000 Aug; 71(8):511-8. PubMed ID: 15326908
[TBL] [Abstract][Full Text] [Related]
18. Emergency eye rinse for chemical injuries: new considerations.
Scott WJ; Schrage N; Dohlman C
JAMA Ophthalmol; 2015 Mar; 133(3):245. PubMed ID: 25474079
[No Abstract] [Full Text] [Related]
19. [Kinetics of drugs in ophthalmology].
Lapalus P; Moulin G; Fredj D
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():31-48. PubMed ID: 2866043
[No Abstract] [Full Text] [Related]
20. In Vivo Studies Evaluating the Use of Contact Lenses for Drug Delivery.
Hui A; Willcox M
Optom Vis Sci; 2016 Apr; 93(4):367-76. PubMed ID: 26784709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
